Ivivi Technologies, Inc.’ PEMF Signals Reduce Post Surgical Pain in Breast Augmentation Patients by 87 Percent, Study Reports

MONTVALE, N.J., July 31, 2008 (PRIME NEWSWIRE) -- Ivivi Technologies’ targeted Pulsed Electromagnetic Field (tPEMF) therapy reduced the pain associated with post-surgical breast augmentation surgery by 87%, with a corresponding reduction in pain medication, researchers reported in the July 2008 issue of Aesthetic Plastic Surgery (http://www.springerlink.com/content/l54978335248u774/?p=22c317e604b941b4bd26e0002d0616cfp=4). Ivivi Technologies, Inc. (Nasdaq:IVVI) is a leader in non-invasive, electroceutical(r) therapy systems designed to target and enhance the body’s anti-inflammatory response.